Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
N Engl J Med. 2022.
PMID: 35403841
Free PMC article.
Clinical Trial.